FDA 483 - Family Fertility Center - June 26, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspected Family Fertility Center in Houston, TX, and found significant issues with their donor screening and eligibility determination processes for reproductive tissues. The firm failed to adequately screen oocyte donors for communicable disease risks, including Zika virus, and did not properly document donor eligibility or retain required records. These deficiencies led to the use of tissues from donors who were not fully assessed or deemed eligible according to regulations.
- Office
- Dallas District Office
- Person
ID · 1724437c-2ce6-413a-91f7-521934680f8d